Graduated from Dept of Medicine, Chongqing Medical College, Chongqing, CHINA(1969); Professor & Postgraduate-student instructor, Clinic Pathophysiology & Immuno-Chemotherapy; Post-doctor training (WHO Fellow) in Dept of Hematology & Oncology, Medical College, Uni. of Arizona, USA; Deputy-Director, Tumor Research Institute, CQMU; Dean, the Qiao-lian Eye Center, CQMU; Lecturer, Dept of Pathology; Vice-chief, Dept of Clinic Diagnostics (Physical Examination Group); Chief, Rural Medical Team, Chongqing Medical College., etc.
1. VISTING WORKS:
Senior Medical Expert, Dept of Medicine, Zhuhai Hokai Group, Guangdong; Director, MMWT clinic immunotherapy program & Senior MD, Dept of Internal Medicine/ Huainan-city Cancer Hospital, Anhui as well as the HIFU-Knife Non-invasive Therapy for Hepatom Program, Dachuan-county Hospital, Sichuan; Visiting professor in Zhuhai, Zhunyi Medical College,etc.
2. HONORS AND AWARDS (partial):
[1]. WHO Fellowship on the Progress of Cancer Therapy, 1986-1988;
[2]. Outstanding Fellow-- List of Dean, University of Arizona Medical College, USA, 1987;
[3]. Distinguished medical teacher, Chongqing University of Med. Sci., 1998;
[4]. First Award, Nature Medicine Product. In: The 2nd ICQG/ 6th ICIM, /11th ICAOM & OMExpo, USC, UCLA, USA, 1999;
[5]. First Award, CHINA National Medical Art Works, 1999;
[6] First Award, Higher Medical Education DVD (Heart Failure), CHINA National Ministry. 2005; [7] 2nd Award, Medical Research Program, the Government of Sichuan Province, CHINA.,etc.
3. PUBLICATIONS (partial):
[1] Chapter-Malabsorption, in:《Medical Cyclopedia of CHINA》.Shanghai Scientific Press, 1987
[2] Chapter 75.,《Practice of Ambulatory Medicine》 [Translate from: Barker LR（Hopkins Uni.
USA）ed]: Chongqing：National Sci.-Tech literature Press，1988.
[3]. Chapter- DIC., etc. 《Pathophysiology (Eng.)》. CHINA-USA Joint Publication: Beijing Scitific Press/ McGrow-Hill Press 2006.
[4]. Repeat infectious syndrome. New Medicine (Dermatol. Vol)，Peoples Health Press，1978，
G-10065.
[5]. Cutaneous manifestation in the patients with Vogt-Koyangi-Hanada syndrome. New Medicine
(Dermatol. Vol). Peoples Health Press，1979.
[6]. Clinic manifestation in cutaneous horn. New Medicine (Dermatol. Vol). Peoples Health Press，
1980.
[7]. Treatment and evaluation for the patients with psoriasis using the combination of 8-MOP plus long wave ultroviolete. Ch J Dermtol.1983
[8]. Chapter- Hypergamaglobulinemia：in: Li Zhongmin ed: 《Clinic differential Diagnostics of symptoms》（3th ed），Shanghai Scientific Press，1995.
[9]. Menzel type atrophy of olive-pone-cerebella. J Ch N-Psych D，1986，12（1）：41-42.
[10]. Contact dermatitis（Translated from: J Japan Dermatol）. New Medicine (Dermatol. Vol)，Peijing：Peoples Health Press，1985（5），S7-85143.
[11]. Vicissitude of death definition —From heart to brain. Translation J HVD. Chendu, 1983，（3）：64
[12]. Slumber & noct-dysrhythmia. Translation J HVD. Chendu, 1983，（3）：49
[13]. Clinic signification of LBBB. Translation J HVD. Chendu, 1982，（4）：52
[14] Possibility-- hydrochlorothiazide used for systemic hypertension. Translation J HVD. Chendu, 1981，（1）：22
[15]. A typical case of Wegner granuloma. CMC Bulletin. 1981，（1）1-4.
[16]. Vitamine C Plus forructus forsythiae—valuabe for common cold. J Chongqing Medice. 1973
[17]. Headache-neckache and Pillow. CHINA Cross Young-Volunteer J. 1976
[18]. Rheumatoid arthritis and cytokines. J Chongqing Medice. 1991
[19]. The levels of Polyamines in the patients with hepatic carcinoma. Berlin’s THE EXCELLENT SCIENTIFIC PAPERS SELECTIONS OF BERLIN INTERNATIONAL MEDICINE 2002,P237-8, Berlin : Germany Academie Europeenne De Sciences Naturelles Publication.
[20]. Research of level of urine glucose in HgCl2 -induced acute renal failure rabbits using ONE TOUCH II. China Practitioner Research J 2002，3(2):1-3. (Hong Kong)
[21]. Research of light- and electro-microscope in HgCl2 -induced acute renal failure rabbits. China Practitioner Research J 2002，3(3):30-33. (Hong Kong)
[22]. Clinical research of polyamines in 62 cases the patients with of malignant tumour. J Chongqing Medicine. 2002，31(4)266-268
[23]. Security analysis for Gold Theragran beverage using Ame’s test. China Practitioner Research J. 2002，3 (4):1-4. (Hong Kong)
[24]. Genetics effect of Gold Theragran to murine cells ——MNT test of cell in bone marrow and Chromosome aberration analysis of testicle spermatospore in murine. China Practitioner Research J 2002，3(5):1-3. (Hong Kong)
[25]. Schedule-dependent interaction of recombinant human tumor necrosis factor (rHuTNF) and doxorubicin against human colon cancer cells. Immunology J. LUO Yun-peng, LIU Rosa，SALMON SE. 2001，17（4）：254-258 [CA:136-323709J, ( 15-Immunochemistay,2002,136 (21):332709)， American Chemical Society ]
[26]. Sensitization of Colon Cancer Cells (COLO205) Treated With Doxorubicin to rHuTNF- Mediated Cytotoxicity CQMU Bulletin，LUO Yunpeng, LIU Rosa，SALMON SE. 2001，26（4）
[27]. Mouse T lymphocytes determined by ANAE assay combined with anti-Thy1-SPA rosette technique. Immunology J， 2000，16（5）：373-376 [CA：135-75411Z , 15-Immuno- chemistay, 2001, 135(6):75412Z,American Chemical Society]
[28] Diseases and disorders of cell proliferation (Chapter 7)；Diseases and apoptosis (Chapter 9). In: Duan Hong, Ed:《Pathophysiology》. Scientific Press, 2006
[29]. 《Expressions of Medical English Idiom》，Hong Kong：Flying-Horse Literature Publication Co，2001，5.
[30]. Chapter-13: Treatment of Cancer & Chapter- 14: Sensitivity and resistance of anticancer agents. In: Fan WK ed:《Modern Oncology》. Beijing：Peoples Heath Press，2005；
[31]. Chapter 3: Dermatopathology [From: Ackeman LV（USA）]: 《Surgical Pathology》. Qindao：CQMC-Qindao MC，1979.
[32]. Clinical observation of hyperthermia combined with Chemotherapy in the treatment of advanced non-small cell lung cancer. Tumour, 2006,26(12):1117-9
[33] Effects of millimeter wave on the homeostasis of PBL Th1/Th2 immune response in cancer patients treated with chemotherapy. Immunology J. 22(5):562-4, 2006 [CA:15-Immuno- chemistay, 2006, American Chemical Society]
[34] Effects of EHF wave radiation on the expression of immunocytes in cancer patients after chemoradiotherapy. Immunology J. 23(4):562-4, 2007 [CA:15-Immunochemistay, 2007, American Chemical Society] ., etc.